ArticleCell proliferation2021

A phase I clinical trial of human embryonic stem cell-derived retinal pigment epithelial cells for early-stage Stargardt macular degeneration: 5-years' follow-up.

Shi-Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.